MSB 4.88% 97.5¢ mesoblast limited

excerpt from attached .The provision refers to proposed product...

  1. 2,649 Posts.
    lightbulb Created with Sketch. 1701

    excerpt from attached .

    The provision refers to proposed product labeling rather than the suggested final printed labeling because we generally review the latter only after an applicant has addressed
    any major deficiencies in an application.

    Dear Phaedrus,
    It appears if the data for the potency assay measures up then we still need to endure final printed labelling approval. Perhaps " stick it in sore spot" will suffice .
    Some light reading for your enjoyment attached.


    My take is we will get an announcement in about 9 trading days stating the potency assay has been accepted/agreed to and approved. But this will not be a full approval/ nor accelerated as
    labelling still to tick off. If I'm right , do you ( someone ) have any idea how long that will take? Two weeks ?

    Reg

    https://www.federalregister.gov/documents/2008/07/10/E8-15608/applications-for-approval-to-market-a-new-drug-complete-response-letter-amendments-to-unapproved
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.5¢
Change
-0.050(4.88%)
Mkt cap ! $1.164B
Open High Low Value Volume
$1.03 $1.04 97.0¢ $4.901M 4.869M

Buyers (Bids)

No. Vol. Price($)
3 28578 97.5¢
 

Sellers (Offers)

Price($) Vol. No.
98.0¢ 101884 11
View Market Depth
Last trade - 12.15pm 24/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.